A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection.
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2009
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriatic arthritis
- Focus Adverse reactions
- Sponsors Wyeth
- 16 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Actual patient number (93) added as reported by ClinicalTrials.gov.